New Delhi, Oct 6 (PTI) Drug firm Rubicon Research on Monday fixed a price band at Rs 461 to Rs 485 per share for its upcoming initial share sale.

The Mumbai-based company is set to raise Rs 1,377.5 crore through its initial public offering (IPO), which will open for subscription on October 9.

The company proposes to utilise the net proceeds from the fresh issue offer towards prepayment or scheduled repayment of all or a portion of certain outstanding borrowings availed by the company, funding inorganic growth through unidentified acquisitions and other strategic initiatives and general corporate purposes, it said in a statement.

The issue will close on October 13, while the bidding for anchor investors will open for a day on October 8.

Rubicon Research’s proposed IPO comprises a fresh

See Full Page